From the Juvenile Arthritis Family Summit to research and advocacy, national efforts shine a light on the resilience of kids ...

Adolescents and young adults with chronic diseases need special care—and pediatric rheumatological conditions can persist ...

Treatment with open-label tofacitinib improved disease activity among patients with sJIA but did not significantly prolong ...

From joint pain and cold weather to diet and exercise, doctors debunk 10 persistent myths about arthritis causes, treatment ...

Nearly 60 million adults and hundreds of thousands of children in the United States are living with arthritis, according to ...

Daisy Maylin, who has juvenile idiopathic arthritis, wants other people to know about the impact of living with JIA after her own diagnosis.

The FDA has approved AbbVie’s RINVOQ (upadacitinib) for the treatment of giant cell arteritis, making it the ninth approved indication for the drug. This also marks the first time an oral JAK ...

A systematic review aimed to assess the specific needs for adolescents and young adults with juvenile idiopathic arthritis (JIA). Data from 1,913 ...

A little girl was diagnosed with arthritis aged TWO – after losing her ability to dance and walk. Daisy Maylin, now four, was ...

Contrary to popular belief, arthritis isn't just an old age ailment; it affects young adults and even children. Early ...

Methotrexate is a cornerstone of therapy worldwide for juvenile idiopathic arthritis, yet there remains vast variability in drug dosing and administration, as well as unpredictable outcomes on the ...